092040.KQ
Amicogen, Inc.
KOE · Healthcare · Biotechnology · KR
KRW 986.00
+2.18%Margins
Gross margin
13.8%
EBITDA margin
-19.3%
EBIT margin
-27.3%
Net margin
-41.3%
FCF margin
-3.6%
-16.4%
Return on equity
-9.8%
Return on assets
-7.2%
Return on invested capital
0.23x
Asset turnover
-KRW 606.3M
Cash from operations
KRW 171
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026